Massive 15,000-Person diabetes drug study launches
NCT ID NCT05926414
Summary
This study aims to see how well two diabetes medications, Envlo and Envlomet SR, control blood sugar in real-world medical practice. It will observe 15,000 adults with type 2 diabetes for 24 weeks to measure changes in their blood sugar levels and check for safety. Unlike a controlled trial, this study simply watches what happens when doctors prescribe these drugs as part of normal patient care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
NaRi Kim
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.